Related Experiment Video
Updated: Jul 19, 2026
05:30
Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery
Published on: January 31, 2025
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.
Sara Arab1, Anthony O Gramolini, Peipei Ping
1Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Journal of the American College of Cardiology
|November 7, 2006
Summary
Proteomics, the study of proteins, offers new ways to detect cardiovascular diseases early and monitor treatment. Advances in technology enable large-scale protein identification for personalized medicine.
Area of Science:
- Biochemistry
- Systems Biology
- Cardiovascular Research
Background:
- Proteomics is a systems biology approach to studying proteins and their variations.
- The field is rapidly evolving due to genome projects and technological advancements.
- Proteomics holds promise for identifying cardiovascular disease biomarkers and improving therapeutic monitoring.
Purpose of the Study:
- To explore the potential of proteomics in cardiovascular disease research.
- To highlight technological advancements in large-scale protein identification.
- To discuss the integration of proteomics with other data for personalized medicine.
Main Methods:
- Large-scale identification of peptide sequences using mass spectrometry.
- Gel-based techniques for analyzing post-translational modifications.
- High-throughput protein evaluation combined with microarray profiling and pathway analysis.
Main Results:
- Proteomic analysis has yielded significant insights into ischemic heart disease, heart failure, and cardiovascular pathophysiology.
- Technological advances facilitate unprecedented large-scale peptide identification.
- The integration of proteomic biomarkers with clinical and genetic data is advancing.
Conclusions:
- Proteomics can lead to earlier detection strategies for cardiovascular diseases.
- Monitoring therapeutic responses can be enhanced through proteomic approaches.
- Combining proteomic biomarkers with clinical and genetic information supports personalized medicine.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...